Leo Luznik

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Leo Luznik, Paul V. O’Donnell, Heather J. Symons et al. · Biology of Blood and Marrow Transplantation · 2008 · 1.9K citations · Full text

Medicine, Hematology, Oncology +16

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak et al. · Blood · 2010 · 404 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

Leo Luznik, Sanju Jalla, Laura Engstrom et al. · Blood · 2001 · 339 citations · Full text

Medicine, Immunology, Oncology +17

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

Jason A. Dubovsky, Ryan Flynn, Jing Du et al. · Journal of Clinical Investigation · 2014 · 199 citations

Life Sciences, Immunology, Pharmacotherapy +16

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Amy E. DeZern, Marianna Zahurak, Heather J. Symons et al. · Blood Advances · 2020 · 149 citations · Full text

Medicine, Hematology, Cell Therapy +16